Matches in Wikidata for { <http://www.wikidata.org/entity/Q64653020> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q64653020 description "clinical trial" @default.
- Q64653020 description "ensayu clínicu" @default.
- Q64653020 description "klinisch onderzoek" @default.
- Q64653020 description "клінічне випробування" @default.
- Q64653020 name "Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice" @default.
- Q64653020 type Item @default.
- Q64653020 label "Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice" @default.
- Q64653020 prefLabel "Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice" @default.
- Q64653020 P1050 Q64653020-CF64E426-C76B-4C47-8BA6-A07561933AED @default.
- Q64653020 P1132 Q64653020-58E4463F-01BB-44B3-95B0-BF89D024C3B1 @default.
- Q64653020 P1476 Q64653020-4F9756D7-EB55-4A8E-A81E-E9FBEE8F82B2 @default.
- Q64653020 P17 Q64653020-176885AF-040E-4909-B975-2BCBD2B49E0F @default.
- Q64653020 P17 Q64653020-1F40D576-E433-4BD8-8C2B-93847D77A901 @default.
- Q64653020 P17 Q64653020-2CB823F1-C04C-414E-BF2E-225CF972EAD3 @default.
- Q64653020 P17 Q64653020-86925FDC-FC9B-4612-B233-B9DBA66F27E2 @default.
- Q64653020 P17 Q64653020-8D0B89EF-FBB2-43F7-ABEC-FC7D4AFEADC9 @default.
- Q64653020 P17 Q64653020-8E9E3891-A1BD-4132-8BFB-BD93CD608AFC @default.
- Q64653020 P17 Q64653020-C39AF75C-0047-4FBD-B374-71641B19619D @default.
- Q64653020 P17 Q64653020-CF461306-E574-48C1-B895-7E4B01EA49FD @default.
- Q64653020 P2899 Q64653020-D343965F-D904-4E9B-879E-7D7914E45631 @default.
- Q64653020 P3098 Q64653020-E0F296FC-9388-4416-A7D9-08678E4F2855 @default.
- Q64653020 P31 Q64653020-A20FAC95-728F-47F3-B3DD-539FB0B8D48E @default.
- Q64653020 P580 Q64653020-160B58BC-E2EB-4A88-A91B-4CF74CBE5BB6 @default.
- Q64653020 P582 Q64653020-8A8B622F-69CC-4CD5-A6AA-502D761E64F1 @default.
- Q64653020 P8363 Q64653020-16808D58-077A-4035-8FB4-263F2E66C3E6 @default.
- Q64653020 P1050 Q179945 @default.
- Q64653020 P1132 "+506" @default.
- Q64653020 P1476 "Effectiveness of Adalimumab (Humira) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice" @default.
- Q64653020 P17 Q191 @default.
- Q64653020 P17 Q212 @default.
- Q64653020 P17 Q213 @default.
- Q64653020 P17 Q214 @default.
- Q64653020 P17 Q215 @default.
- Q64653020 P17 Q218 @default.
- Q64653020 P17 Q28 @default.
- Q64653020 P17 Q801 @default.
- Q64653020 P2899 "+18" @default.
- Q64653020 P3098 "NCT01202565" @default.
- Q64653020 P31 Q30612 @default.
- Q64653020 P580 "2010-09-01T00:00:00Z" @default.
- Q64653020 P582 "2013-07-01T00:00:00Z" @default.
- Q64653020 P8363 Q818574 @default.